Most cited papers from AlzeCure Pharma (Sweden)

AlzeCure Pharma (Sweden)

What are the most cited papers from AlzeCure Pharma (Sweden)?

The most cited paper from AlzeCure Pharma (Sweden) is "Neurotrophin-targeted therapeutics: A gateway to cognition and more?" (Gunnar Nordvall, Pontus K. A. Larsson Forsell, Johan Sandin, 2022), with 50 citations. Next come "Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis" (46) and "Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice" (45).

Published TypeFieldAccess

Showing 25 of 25 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Neurotrophin-targeted therapeutics: A gateway to cognition and more? Gunnar Nordvall, Pontus K. A. Larsson Forsell, Johan Sandin · Drug Discovery Today Open access	16 Jul 2022	50
2	Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis Hannes Odelram, Bengt Björkstén, T. AF KLERCKER et al. · Allergy	Aug 1989	46
3	Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice Beatriz Merino, Cristina M. Fernández-Díaz, Cristina Parrado‐Fernández et al. · Metabolism Open access	9 Sep 2020	45
4	Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease Gunnar Nordvall, Johan Lundkvist, Johan Sandin · Frontiers in Molecular Neuroscience Open access	16 Oct 2023	39
5	Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling Luana Naia et al. · BMC Biology Open access	24 Mar 2021	39
6	Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction Märta Dahlström, Nather Madjid, Gunnar Nordvall et al. · Cells Open access	23 Jul 2021	35
7	Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model Daniel V. Oliveira, Kirsten Coupland, Wenchao Shao et al. · EMBO Molecular Medicine Open access	16 Dec 2022	29
8	Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept? Nather Madjid, Veronica Lidell, Gunnar Nordvall et al. · Psychopharmacology Open access	3 Jul 2023	21
9	Neuroprotective and Disease-Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease Cristina Parrado Fernández, Sanja Juric, Maria Backlund et al. · International Journal of Molecular Sciences Open access	6 Jul 2023	16
10	Sex difference in flux of 27‐hydroxycholesterol into the brain Cristina Parrado‐Fernández, Valerio Leoni, Ahmed Saeed et al. · British Journal of Pharmacology Open access	21 Dec 2020	15
11	Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease Pontus K. A. Larsson Forsell, Cristina Parrado Fernández, Boel Nilsson et al. · Pharmaceuticals Open access	28 Jul 2024	14
12	Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double‐blind, placebo‐controlled, crossover study Märta Segerdahl, M. Rother, Magnus M. Halldin et al. · European Journal of Pain Open access	12 Jun 2024	13
13	Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects Kristin Önnestam, Björn Mikael Nilsson, M. Rother et al. · The Journal of Prevention of Alzheimer s Disease Open access	6 Jul 2023	11
14	γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing Tobias A. Weber, Johan Lundkvist, Johanna Wanngren et al. · Journal of Cellular and Molecular Medicine Open access	20 Dec 2021	9
15	Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand Dinahlee Saturnino Guarino, Patrícia Miranda-Azpiazu, Dan Sunnemark et al. · ACS Chemical Neuroscience Open access	11 Nov 2024	8
16	Identification of amino acid residues of nerve growth factor important for neurite outgrowth in human dorsal root ganglion neurons Märta Dahlström, Gunnar Nordvall, Erik Sundström et al. · European Journal of Neuroscience Open access	13 Jul 2019	7
17	ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics Boel Nilsson, Johan Bylund, Magnus M. Halldin et al. · European Journal of Clinical Pharmacology Open access	14 Feb 2024	6
18	Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover study Adriana Ana Miclescu, Rolf Karlsten, Ingrid Lönnstedt et al. · Scandinavian Journal of Pain Open access	2025	3
19	Development and In Vitro Characterization of [3H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies Andrea Varrone, Vasco C. Sousa, Manolo Mugnaini et al. · Cells Open access	9 Jun 2025	1
20	Modulation of the NGF – TRKA pathway for treatment of joint pain: preclinical in vivo evaluation in mice Kristina Ängeby Möller, Pontus K. A. Larsson Forsell, Gunnar Nordvall et al. · Osteoarthritis and Cartilage Open access	Apr 2018	1
21	Analgesic, anti-inflammatory and joint protective effects of ACD137, a selective negative allosteric modulator of TrkA, in models of chemotherapy-induced peripheral neuropathy and osteoarthritis Pontus K. A. Larsson Forsell, Maria Backlund, Veronica Lidell et al. · Scandinavian Journal of Pain Open access	2026	0
22	Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism Chiara Bertasini, Marco Rossini, Jacopo Grisotto et al. · Experimental Neurology Open access	23 Sep 2025	0
23	Results From a Multiple Ascending Dose Study in Healthy Volunteers of ACD856, a Positive Modulator of Neurotrophin Trk‐Receptors Kristin Önnestam, Boel Nilsson, M. Rother et al. · Alzheimer s & Dementia	Dec 2022	0
24	NOTCH3 active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model Daniel V. Oliveira, Kirsten Coupland, Shaobo Jin et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	12 Jul 2022	0
25	P.0229 Characterization of positive allosteric modulators of trkb for the treatment of depression Johan Sandin, Gunnar Nordvall, Märta Dahlström et al. · European Neuropsychopharmacology	Dec 2021	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.